Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
about
Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastasesHepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancerPreoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionAdjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysisColorectal cancer: Metastases to a single organA multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literatureMultisciplinary management of patients with liver metastasis from colorectal cancerColorectal Liver Metastases: A Critical Review of State of the ArtUnresolved issues and controversies surrounding the management of colorectal cancer liver metastasisLong Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential BiomarkerFirst clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.A Novel Computational Tool for Mining Real-Life Data: Application in the Metastatic Colorectal Cancer Care Setting.Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapyLocal Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial.Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis.18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?Multidisciplinary approach of colorectal cancer liver metastases.Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic reviewLiver Metastasectomy and Systemic Therapy Improve Overall Survival Compared With Surgery Alone After Curative Liver Resection of Colorectal Metastases in a Developing Country (Costa Rica).Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable--a meta-analysis.Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy aloneStrategies for Management of Synchronous Colorectal Metastases.Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Management of oligometastatic rectal cancer: is liver first?Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver MPrognostic value of Ki-67 expression in conversion therapy for colorectal liver-limited metastasesAssessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control StudyImpact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases.The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.Variation in hospital treatment patterns for metastatic colorectal cancer.Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled TrialSurgical Referral for Colorectal Liver Metastases: A Population-Based Survey.Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agentsPredictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
P2860
Q26744398-33E1632E-5D49-4024-95C6-752972E4AC6FQ26772267-6885383C-4295-4A64-8B8C-5851223AE82CQ26774687-B49D6E22-F0E7-4A46-938F-1991EA8CFE15Q26774704-E883E343-3CDA-4B3B-B589-7E7D84F6DDD4Q26778009-7A9B089B-F297-4307-BF44-6B6CE40F7256Q26800770-3183552D-B930-4B5A-B20D-D7241387752BQ28069575-596A3E72-7403-48F3-91BE-FCEE93132421Q28070400-8F02861A-8AD3-436A-A9CB-8E1C54A37F93Q28085651-E535A744-6D0A-4EBF-A2AC-FA4CD7307B39Q28088492-9CCBFA4E-2106-4197-AF93-7112DA3FA570Q30417323-9C2BB396-0F47-4D28-86EA-B8632E936BA6Q31090273-08C4272B-4FFE-4A5E-AF21-FFB9CF9F1054Q33555345-D0985C0E-0CC3-4E5F-8363-5B1CFC138CB5Q33558347-10336875-0649-426B-AF34-FFE9B828998CQ33614301-680907A3-3F7A-4423-9337-497E9BD52B14Q33656676-F4EEEDFA-992D-4B36-ABF3-3DB0A2B7FD4FQ33695043-DB4E30FF-A7AC-4604-A848-14074900F14BQ33776697-22A3FB47-77C1-4B77-9077-68DC99770FCCQ33779859-6B08A97A-8110-4560-857D-1E92DD10C9E5Q33779885-70EE5571-4DD2-4E52-BCFB-51E77194349FQ33859578-3D4BE0E3-8B3B-41DC-AD16-C25722EF5F79Q34004989-7A12F4DC-012A-4412-9E5D-29C4864CB7F5Q34354500-30E0ACF6-AC3F-4314-B85C-82C157D2A617Q34572707-B7AC8A6C-4239-4E08-8E68-4E12BB91725BQ34664272-58829E5D-7905-453D-BF65-C6CAED3969C9Q35029056-6C8F16BA-F251-4DCF-A913-CE4DBD25144CQ35225671-0F2B4FC0-C891-45F8-80F9-D620DD8806D7Q35331858-9D00E33A-BD19-4C51-A166-7CBFE9D043F7Q35625828-1D40744C-F1C7-4FB1-98F0-FE3357F32F95Q35666492-C183A0C0-1BF9-4D36-A269-48AD0307629DQ35918413-E712B390-1D4F-41CD-8912-D7285D0D5C38Q35920259-03A482A3-C859-4F31-B106-3DCFC6160FE3Q35988684-73378FA5-B72A-46F6-AC3C-5D451ABF8ECEQ36089548-3DA11CC2-728D-404D-9EF1-38E085F54BCBQ36117240-BFEFFF88-A79D-4CD2-A066-1FDDFD25CD71Q36121535-701AA599-4358-4C0C-9D0F-9038FB470DD7Q36244515-688F7DB5-AD64-4DE5-862E-CBED2BB76C14Q36258276-DF39503C-E9F1-475B-AB68-F2EC6382D218Q36343047-4A30134F-C68A-47D1-8D63-E6348AC775AEQ36344123-9C545B7A-3CA0-4FD6-B4DB-4EA8C44A7570
P2860
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@ast
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@en
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@nl
type
label
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@ast
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@en
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@nl
prefLabel
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@ast
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@en
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@nl
P2093
P50
P921
P1433
P1476
Perioperative FOLFOX4 chemothe ...... ed, controlled, phase 3 trial.
@en
P2093
Arbeitsgruppe Lebermetastasen ...... meinschaft Onkologie (ALM-CAO)
Australasian Gastro-Intestinal Trials Group (AGITG)
Bernard Nordlinger
Cancer Research UK
Darius Mirza
EORTC Gastro-Intestinal Tract Cancer Group
Erik Tanis
Fédération Francophone de Cancérologie Digestive (FFCD)
Graeme J Poston
Halfdan Sorbye
P304
P356
10.1016/S1470-2045(13)70447-9
P577
2013-10-11T00:00:00Z